Global Bone Morphogenetic Protein (BMP) 2 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI01252225

Publication Date:

January 10, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Bone Morphogenetic Protein (BMP) 2 market size is predicted to grow from US$ 682 million in 2025 to US$ 1160 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive鈥攐ne of the three main categories of bone grafts鈥攁nd play an active role in bone formation and maintenance.
Bone Morphogenetic Protein 2 (BMP-2) is a member of the bone morphogenetic protein family, a group of proteins that play a crucial role in bone and cartilage formation during embryonic development and adult tissue repair. BMP-2 is known for its potent osteoinductive properties, meaning it has the ability to stimulate the differentiation of mesenchymal stem cells into osteoblasts, the cells responsible for bone formation. This property makes BMP-2 a valuable therapeutic agent in orthopedic and dental surgeries, particularly in procedures aimed at promoting bone regeneration and spinal fusion.
Global core manufacturers of Bone Morphogenetic Protein (BMP) 2 include Medtronic, Jiuyuan Gene Engineering and Cellumed. North America is the largest consumption region, accounting for approximately 69% of the global market, followed by Asia-Pacific. In terms of product type, sponge is the largest market segment, with a share of more than 81%. In terms of application, the largest application is spinal fusion, with a share of approximately 68%.
The 鈥淏one Morphogenetic Protein (BMP) 2 Industry Forecast鈥� looks at past sales and reviews total world Bone Morphogenetic Protein (BMP) 2 sales in 2024, providing a comprehensive analysis by region and market sector of projected Bone Morphogenetic Protein (BMP) 2 sales for 2025 through 2031. With Bone Morphogenetic Protein (BMP) 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Morphogenetic Protein (BMP) 2 industry.
This Insight Report provides a comprehensive analysis of the global Bone Morphogenetic Protein (BMP) 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bone Morphogenetic Protein (BMP) 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bone Morphogenetic Protein (BMP) 2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Morphogenetic Protein (BMP) 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Morphogenetic Protein (BMP) 2.
This report presents a comprehensive overview, market shares, and growth opportunities of Bone Morphogenetic Protein (BMP) 2 market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sponge
Gel
Segmentation by Application:
Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
reconstructive surgery
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Jiuyuan Gene Engineering
Cellumed

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size (2020-2031)
2.1.2 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Bone Morphogenetic Protein (BMP) 2 by Country/Region (2020, 2024 & 2031)
2.2 Bone Morphogenetic Protein (BMP) 2 Segment by Type
2.2.1 Sponge
2.2.2 Gel
2.3 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Type
2.3.1 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Bone Morphogenetic Protein (BMP) 2 Segment by Application
2.4.1 Spinal Fusion
2.4.2 Trauma Surgery
2.4.3 Oral Maxillofacial Surgery
2.4.4 reconstructive surgery
2.5 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Application
2.5.1 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Player
3.1 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Player (2020-2025)
3.1.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Bone Morphogenetic Protein (BMP) 2 Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bone Morphogenetic Protein (BMP) 2 by Region
4.1 Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Region (2020-2025)
4.2 Global Bone Morphogenetic Protein (BMP) 2 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size Growth (2020-2025)
4.4 APAC Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size Growth (2020-2025)
4.5 Europe Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Country (2020-2025)
5.2 Americas Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Type (2020-2025)
5.3 Americas Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Region (2020-2025)
6.2 APAC Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Type (2020-2025)
6.3 APAC Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Country (2020-2025)
7.2 Europe Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Type (2020-2025)
7.3 Europe Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 by Region (2020-2025)
8.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Bone Morphogenetic Protein (BMP) 2 麻豆原创 Forecast
10.1 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Region (2026-2031)
10.1.1 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Region (2026-2031)
10.1.2 Americas Bone Morphogenetic Protein (BMP) 2 Forecast
10.1.3 APAC Bone Morphogenetic Protein (BMP) 2 Forecast
10.1.4 Europe Bone Morphogenetic Protein (BMP) 2 Forecast
10.1.5 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Forecast
10.2 Americas Bone Morphogenetic Protein (BMP) 2 Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.2.2 Canada 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.2.3 Mexico 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.2.4 Brazil 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.3 APAC Bone Morphogenetic Protein (BMP) 2 Forecast by Region (2026-2031)
10.3.1 China Bone Morphogenetic Protein (BMP) 2 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.3.3 Korea 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.3.4 Southeast Asia 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.3.5 India 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.3.6 Australia 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.4 Europe Bone Morphogenetic Protein (BMP) 2 Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.4.2 France 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.4.3 UK 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.4.4 Italy 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.4.5 Russia 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.5 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.5.2 South Africa 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.5.3 Israel 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.5.4 Turkey 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
10.6 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Type (2026-2031)
10.7 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Bone Morphogenetic Protein (BMP) 2 Forecast
11 Key Players Analysis
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Bone Morphogenetic Protein (BMP) 2 Product Offered
11.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Medtronic Main Business Overview
11.1.5 Medtronic Latest Developments
11.2 Jiuyuan Gene Engineering
11.2.1 Jiuyuan Gene Engineering Company Information
11.2.2 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product Offered
11.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Jiuyuan Gene Engineering Main Business Overview
11.2.5 Jiuyuan Gene Engineering Latest Developments
11.3 Cellumed
11.3.1 Cellumed Company Information
11.3.2 Cellumed Bone Morphogenetic Protein (BMP) 2 Product Offered
11.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Cellumed Main Business Overview
11.3.5 Cellumed Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.